{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/61958-2501#drug","name":"Biktarvy","alternateName":"bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"61958-2501"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"NDA210251"},{"@type":"PropertyValue","propertyID":"UNII","value":"FWF6Q91TZO|4L5MP1Y7W7|G70B4ETF4S"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"664cb8f0-1f65-441b-b0d9-ba3d798be309"}],"activeIngredient":"BICTEGRAVIR SODIUM, EMTRICITABINE, TENOFOVIR ALAFENAMIDE FUMARATE","administrationRoute":["ORAL"],"dosageForm":"TABLET","manufacturer":{"@type":"Organization","name":"Gilead Sciences, Inc."},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/NDA210251","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=664cb8f0-1f65-441b-b0d9-ba3d798be309","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=61958-2501"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-04T05:49:58.235Z"}}